Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone. 1994

C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
Charles Salt Research Centre, Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry, Shropshire, England.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010001 Osteitis Deformans A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry. Paget's Disease of Bone,Osseous Paget's Disease,Paget Disease of Bone,Paget Disease, Bone,Pagets Disease, Bone
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004164 Diphosphonates Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. Bisphosphonate,Bisphosphonates
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006909 Hydroxyproline A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation. Oxyproline,4-Hydroxyproline,cis-4-Hydroxyproline,4 Hydroxyproline,cis 4 Hydroxyproline
D000077268 Pamidronate An aminobisphosphonate that inhibits BONE RESORPTION and is used for the treatment of osteolytic lesions, bone pain, and severe HYPERCALCEMIA associated with malignancies. (3-Amino-1-hydroxypropylidene)-1,1-biphosphonate,1-Hydroxy-3-aminopropane-1,1-diphosphonic acid,AHPrBP,Amidronate,Amino-1-hydroxypropane-1,1-diphosphonate,Aminohydroxypropylidene Diphosphonate,Aminopropanehydroxydiphosphonate,Aredia,Pamidronate Calcium,Pamidronate Disodium,Pamidronate Monosodium,Pamidronic Acid,1 Hydroxy 3 aminopropane 1,1 diphosphonic acid,Amino 1 hydroxypropane 1,1 diphosphonate
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
January 1981, Metabolic bone disease & related research,
C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
May 1999, Bone,
C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
October 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
November 1997, Scandinavian journal of clinical and laboratory investigation,
C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
January 2001, Annales de biologie clinique,
C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
November 2001, Bone,
C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
June 2000, Bone,
C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
January 1989, Schweizerische medizinische Wochenschrift,
C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
September 1998, Annals of the rheumatic diseases,
C A Sharp, and M Worsfold, and P R Rowlands, and M W Davie
March 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Copied contents to your clipboard!